2021
DOI: 10.1002/cam4.3788
|View full text |Cite
|
Sign up to set email alerts
|

Low‐grade chronic inflammation and immune alterations in childhood and adolescent cancer survivors: A contribution to accelerated aging?

Abstract: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
16
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(16 citation statements)
references
References 43 publications
0
16
0
Order By: Relevance
“…Pediatric cancer survivors differ from age-related controls in terms of activation of the adaptive immune system, chronic, low-grade inflammation, as well as immune tolerance resulting from the synthesis of immunomodulators via the tryptophan-kynurenine metabolic pathway [ 127 ]. These changes resemble an aging phenotype observed in older populations [ 128 ] and are indicative of allostatic load [ 127 ]. Some research shows that pediatric cancer survivors have increased biological age relative to their chronological age, as indicated by shortened telomeres [ 104 , 105 ], epigenetic age acceleration [ 106 ] and biochemical and molecular markers such as inefficient oxidative phosphorylation, increased lipid peroxidation and decreased expression of metabolic proteins and those involved in mitochondrial biogenesis [ 107 ].…”
Section: Target Organ Activationmentioning
confidence: 83%
“…Pediatric cancer survivors differ from age-related controls in terms of activation of the adaptive immune system, chronic, low-grade inflammation, as well as immune tolerance resulting from the synthesis of immunomodulators via the tryptophan-kynurenine metabolic pathway [ 127 ]. These changes resemble an aging phenotype observed in older populations [ 128 ] and are indicative of allostatic load [ 127 ]. Some research shows that pediatric cancer survivors have increased biological age relative to their chronological age, as indicated by shortened telomeres [ 104 , 105 ], epigenetic age acceleration [ 106 ] and biochemical and molecular markers such as inefficient oxidative phosphorylation, increased lipid peroxidation and decreased expression of metabolic proteins and those involved in mitochondrial biogenesis [ 107 ].…”
Section: Target Organ Activationmentioning
confidence: 83%
“…In particular, in childhood cancer survivors (CCS) a premature aging process is observed which induces the damage of vital organs and, consequently, the onset of chronic age-related diseases, such as osteoporosis, cardiovascular diseases, obesity, and infertility [4,[37][38][39][40]. This condition is named frailty and is subsequent to a low-grade systemic chronic inflammation, inflamm-aging, caused by chemo-and radiotherapy insults [35]. Anti-neoplastic therapies are responsible for inflammation and for an increase of senescent cells, DNA mutation, and oxygen reactive species (ROS) production [12,13].…”
Section: Discussionmentioning
confidence: 99%
“…Recently, Sulicka-Grodzicka et al evaluated factors discriminating CS from controls, comparing selected biomarkers and lymphocyte subpopulations. They demonstrated that survivors had higher levels of C-reactive protein (CRP) and a shift towards activated CD8+CD38+ T cells [ 35 ]. CD38 is an important marker that regulates activation and proliferation of human T lymphocytes.…”
Section: Inflamm-aging and Immune System Alterationsmentioning
confidence: 99%
See 1 more Smart Citation
“…In the elderly, the activation status by only CD38 has been found to be decreased and by only HLA-DR increased in CD8 + T cells in elderly (Qin et al, 2016). Interestingly, terminally differentiated CD8 + T cells do not show a senescent phenotype in CCS like in elderly, while the central memory CD8 + and CD4 + T cells increase in both, CCS and elderly (Saule et al, 2006;Sulicka-Grodzicka et al, 2021).…”
Section: T Cellsmentioning
confidence: 96%